טוען...
IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
Tumor necrosis factor-α (TNF-α)-inhibiting agents are a standard therapy for moderate-to-severe inflammatory bowel disease (IBD). IgA nephropathy in the setting of prolonged exposure to TNF-α inhibitors is a rare, clinically significant adverse event often overlooked by gastroenterologists but well...
שמור ב:
| הוצא לאור ב: | ACG Case Rep J |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526714/ https://ncbi.nlm.nih.gov/pubmed/33062795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.0000000000000462 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|